About
Looking for more information?
Contact our responsive and friendly client services team any time.
(03) 9028 2888
clients@freshequities.com
Current price
$0.061
▾0.00 (0.00%)
Last trade: Invalid date GMT
Market cap
$42.82m
20 min delay
Investor Presentations
Principal Activity
Biotron Limited (BIT) is a biotechnology company engaged in research, development, and commercialisation of drugs targeting viral diseases with unmet medical need. The Company focuses on the progression of the clinical development of the drug, BIT225, an investigational, orally-administered, novel antiviral compound in development by Biotron for treatment of HCV and HIV infections.
Address
19/56 Delhi Rd, Macquarie Park NSW 2113, Australia
Website
News
Announcements
Filter
| Announcement | T+2 Movement | Date |
|---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
-
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
| Company | Market Cap | ||
|---|---|---|---|
Support
Live Chat
Markets
Contact Us
(03) 9028 2888
clients@freshequities.com
Address
Level 19, 15 William St
Melbourne VIC 3000
Australia